Psyence Biomedical Ltd.
PBM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.24M in total; no superinvestor holds it.
Other share classesPBMWW
13F holders, Q4 2024
Institutional positions in Psyence Biomedical Ltd. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −1 vs. Q3 2024
- Shares held
- 749.9K
- −1.26M (−62.8%) vs. Q3 2024
- Total value
- $1.53M
- +$1.33M (+662.9%) vs. Q3 2024
- New holders
- 6
- 1 more added
- Sold out
- 7
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $1.24M |
| Q1 2026 | 2 | $575.0K |
| Q4 2025 | 5 | $718.4K |
| Q3 2025 | 6 | $763.7K |
| Q2 2025 | 6 | $625.3K |
| Q1 2025 | 8 | $272.8K |
| Q4 2024 | 11 | $1.53M |
| Q3 2024 | 12 | $200.8K |
| Q2 2024 | 10 | $279.8K |
| Q1 2024 | 10 | $830.9K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Psyence Biomedical Ltd.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 380,000 | $743.7K | 0.00% | +380,000 | New |
| Harraden Circle Investments, LLC | 182,323 | $384.7K | 0.31% | +182,323 | New |
| Essential Planning, LLC. | 73,278 | $162.6K | 0.00% | +73,278 | New |
| AdvisorShares Investments LLC | 26,923 | $56.8K | 0.01% | −1,205,453−97.8% | Reduced |
| HRT Financial LP | 26,127 | $55.0K | 0.00% | +362+1.4% | Added |
| Virtu Financial LLC | 12,692 | $27.0K | 0.00% | +12,692 | New |
| UBS Group AG | 12,712 | $26.8K | 0.00% | −2,318−15.4% | Reduced |
| Citadel Advisors LLC | 11,490 | $24.2K | 0.00% | −157,761−93.2% | Reduced |
| Scientech Research LLC | 11,183 | $23.6K | 0.01% | +11,183 | New |
| Connective Capital Management, LLC | 11,149 | $23.5K | 0.03% | +11,149 | New |
| Tower Research Capital LLC (TRC) | 1,993 | $4.21K | 0.00% | −32,398−94.2% | Reduced |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −337,000−100.0% | Sold out |
| Stonehage Fleming Financial Services Holdings Ltd | 0 | $0 | 0.00% | −80,500−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −48,407−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −45,963−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,989−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −10,488−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |